Lexeo Therapeutics Inc (LXEO)

05:03 AM

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

05:03 AM

Mar 09, 2026

Lexeo Therapeutics (NASDAQ:LXEO) Shares Up 10.4%What's Next? - MarketBeat

Mar 09, 2026

Mar 08, 2026

Sectors Review: Is Lexeo Therapeutics Inc. subject to activist investor interestWeekly Trade Summary & Low Volatility Stock Suggestions - baoquankhu1.vn

Mar 08, 2026

Mar 08, 2026

Is Lexeo Therapeutics Inc a cyclical or defensive stockMarket Volume Report & Daily Growth Stock Investment Tips - baoquankhu1.vn

Mar 08, 2026

Mar 06, 2026

Published on: 2026-03-07 09:09:20 - baoquankhu1.vn

Mar 06, 2026

Mar 03, 2026

Lexeo Therapeutics to Participate in the Leerink Global Healthcare Conference - The Manila Times

Mar 03, 2026

Mar 01, 2026

Nasdaq Moves: Can Lexeo Therapeutics Inc ride the EV waveRate Cut & Safe Capital Growth Trade Ideas - baoquankhu1.vn

Mar 01, 2026

Feb 28, 2026

Lexeo Therapeutics Highlights FA and PKP2 Cardiac Gene Therapy Progress at Oppenheimer Conference - MarketBeat

Feb 28, 2026

Feb 25, 2026

LXEO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 25, 2026

Feb 24, 2026

Earnings Update: Is Lexeo Therapeutics Inc forming a bullish divergenceProduct Launch & Consistent Profit Focused Trading Strategies - baoquankhu1.vn

Feb 24, 2026

Feb 24, 2026

Profit Review: Is Lexeo Therapeutics Inc forming a bullish divergenceShare Buyback & Risk Controlled Stock Alerts - baoquankhu1.vn

Feb 24, 2026

Feb 23, 2026

Narinder Pal Bhalla Net Worth (2026) - GuruFocus

Feb 23, 2026

Feb 23, 2026

Insider Selling: Lexeo Therapeutics (NASDAQ:LXEO) CEO Sells $64,903.74 in Stock - Defense World

Feb 23, 2026

Feb 23, 2026

Lexeo Therapeutics (NASDAQ:LXEO) COO Sells $19,302.40 in Stock - Defense World

Feb 23, 2026

Feb 21, 2026

Will Lexeo Therapeutics Inc. outperform its industry peersEarnings Risk Summary & Capital Efficient Trade Techniques - mfd.ru

Feb 21, 2026

Feb 20, 2026

Balyasny Asset Management L.P. Increases Stake in Lexeo Therapeu - GuruFocus

Feb 20, 2026

Feb 20, 2026

Top Brass at Biotech Player Quietly Cash Out in Latest Insider Move - TipRanks

Feb 20, 2026

Feb 20, 2026

Balyasny Asset Management L.P. Increases Stake in Lexeo Therapeutics Inc. - GuruFocus

Feb 20, 2026

Feb 18, 2026

LXEO (NASDAQ: LXEO) affiliate plans sale of 4,867 vested shares - Stock Titan

Feb 18, 2026

Feb 18, 2026

LXEO (NASDAQ: LXEO) Form 144 reports 3,861 shares tied to vesting - Stock Titan

Feb 18, 2026

Feb 17, 2026

LXEO Should I Buy - Intellectia AI

Feb 17, 2026

Feb 17, 2026

Citadel discloses 7.4% Lexeo Therapeutics (LXEO) ownership in 13G/A - Stock Titan

Feb 17, 2026

Feb 16, 2026

BioAgilytix Labs, Inc Receives FDA Breakthrough Device Designation for Anti-AAV Antibody Assay - The Courier-Journal

Feb 16, 2026

Feb 16, 2026

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Feb 16, 2026

Feb 15, 2026

Published on: 2026-02-16 16:57:11 - baoquankhu1.vn

Feb 15, 2026

Feb 15, 2026

Is Lexeo Therapeutics Inc. still a buy after recent gainsJuly 2025 Earnings & Fast Entry Momentum Trade Alerts - mfd.ru

Feb 15, 2026

Feb 14, 2026

Lexeo Therapeutics Details FDA Path for LX2006, Highlights LVMI Gains at Guggenheim Biotech Summit - MarketBeat

Feb 14, 2026

Feb 14, 2026

A | Does Lexeo Therapeutics, Inc. have declining or rising EPSPortfolio Update Report & Weekly Watchlist of Top Performers - mfd.ru

Feb 14, 2026

Feb 14, 2026

Page not foundAirwhon - MarketBeat

Feb 14, 2026

Feb 13, 2026

Lexeo Therapeutics (NASDAQ:LXEO) Stock Price Down 3.2%Time to Sell? - MarketBeat

Feb 13, 2026

Feb 12, 2026

Will Lexeo Therapeutics Inc. announce a stock splitJuly 2025 Spike Watch & Smart Allocation Stock Reports - mfd.ru

Feb 12, 2026

Feb 08, 2026

Volatility Watch: Is Lexeo Therapeutics Inc backed by strong institutional buyingPortfolio Return Report & Low Risk High Reward Ideas - baoquankhu1.vn

Feb 08, 2026

Feb 07, 2026

Lexeo Therapeutics Announces Head of Research Transition - The Globe and Mail

Feb 07, 2026

Feb 06, 2026

Lexeo Therapeutics (LXEO) CFO receives RSUs and 226,665-share stock option - Stock Titan

Feb 06, 2026

Feb 05, 2026

Lexeo Therapeutics to Participate in Upcoming Investor Conferences in February - 富途牛牛

Feb 05, 2026

Feb 02, 2026

H.C. Wainwright Says Market Remains Unconvinced on Lexeo Therapeutics, Inc. (LXEO)’s PKP2 Program - Yahoo Finance

Feb 02, 2026

Feb 02, 2026

H.C. Wainwright Says Market Remains Unconvinced on Lexeo Therapeutics, Inc. (LXEO)'s PKP2 Program - Finviz

Feb 02, 2026

Jan 30, 2026

Lexeo TherapeuticsRevolutionizing Heart Health With Gene Therapies - RTTNews

Jan 30, 2026

Jan 28, 2026

Lexeo Therapeutics Announces Key Executive Leadership Changes - The Globe and Mail

Jan 28, 2026

Jan 27, 2026

Lexeo Therapeutics Announces Key Leadership Appointments - citybiz

Jan 27, 2026

Jan 27, 2026

Lexeo Therapeutics appoints new COO and CMO, announces executive transition - Investing.com Nigeria

Jan 27, 2026

Jan 27, 2026

Lexeo Therapeutics appoints new COO and CMO, announces executive transition By Investing.com - Investing.com South Africa

Jan 27, 2026

Jan 27, 2026

Lexeo Therapeutics Announces Executive Appointments - marketscreener.com

Jan 27, 2026

Jan 27, 2026

Lexeo Therapeutics Announces Key Executive Appointments - TradingView

Jan 27, 2026

Jan 27, 2026

Lexeo Therapeutics announces key leadership appointments By Investing.com - Investing.com Canada

Jan 27, 2026

Jan 27, 2026

Lexeo appoints Jose Manuel Otero as COO - TipRanks

Jan 27, 2026